Dyax Corp (NASDAQ: DYAX) is on watch as an FDA panel reviewed Eli Lilly & Co.'s (NYSE: LLY) experimental ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE